TacticScale

What Agilent Technologies Does & How It Makes Money (A)

Updated October 2026 · reflects Agilent Technologies's latest reported financials

Maker of lab instruments, software, and services for life sciences and chemistry. Agilent sells analytical instruments such as chromatography, mass spectrometry, and spectroscopy systems, and then earns recurring revenue from consumables, software, and services like repairs, maintenance, and compliance support for its installed base.

Agilent Technologies

Agilent Technologies's story, moat and numbers — in a 3-minute visual book.

Read the illustrated, narrated story →

How Agilent Technologies makes money

Agilent sells analytical instruments such as chromatography, mass spectrometry, and spectroscopy systems, and then earns recurring revenue from consumables, software, and services like repairs, maintenance, and compliance support for its installed base. It sells through direct sales, distributors, resellers, representatives, and e-commerce.

What Agilent Technologies does

Agilent Technologies provides instruments, software, consumables, and services to labs in the life sciences, diagnostics, and applied chemical markets. It has three segments. Life Sciences and Diagnostics Markets covers liquid chromatography and LC mass spectrometry systems, plus genomics, pathology, companion diagnostics, biomolecular analysis, and contract development and manufacturing (CDMO). Applied Markets offers gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. The Agilent CrossLab segment is the recurring-revenue side of the business. It sells columns, sample preparation products, custom chemistries, and lab supplies, along with software such as the OpenLab platform and informatics for instrument control, data analysis, and lab workflow management. It also provides repairs, maintenance, training, compliance support, and consulting. Agilent was incorporated in 1999 and is headquartered in Santa Clara, California.

Products & services

What is Agilent Technologies worth?

On an owner-earnings DCF, Agilent Technologies's most-likely value is about $110 versus a recent price near $171 (36% above fair value). But TacticScale only calls a stock undervalued when the price sits below its conservative no-growth floor (~$52) with a margin of safety — so the honest verdict here is “Fairly priced — no edge.” Fair value earns its keep only at the extremes, not in the wide middle.

Verdict: Fairly priced — no edge
Owner-earnings fair value · recent price ≈ $171
Fair value (most likely)
$110
Range
$82–$162
No-growth floor
$52
Price
~$171

Price sits in the normal range — fair value isn't actionable here; it earns its keep only when price drops below the no-growth floor, or runs to roughly double the optimistic case.

Analysis, not advice. Fair value is a margin-of-safety estimate from a deterministic owner-earnings DCF, not a price target or recommendation. See the full breakdown →

Sector Healthcare Industry Diagnostics & Research HQ United States Ticker A Moat Narrow moat (66/100) Official site

Related companies

Danaher (DHR) · Thermo Fisher Scientific (TMO) · Waters (WAT) · Avantor (AVTR) · Bio-Techne (TECH)